遗传缺陷在某些病人中被认为是导致原发性肌张力障碍的原因。
Genetic defects are believed responsible for the primary dystonia in some patients.
FDA已经批准DBS用于治疗神经系统疾病，其中包括原发性震颤、帕金森症、肌张力障碍及重度强迫症。
The FDA has already approved DBS as a treatment for neurologic disorders, including essential tremor, Parkinson's disease, dystonia, and severe obsessive-compulsive disorder.
FDA已经批准DBS用于治疗神经系统疾病，其中包括原发性震颤、帕金森症、肌张力障碍及重度强迫症。
The FDA has already approved DBS as a treatment for neurologic disorders, including essential tremor, Parkinson's disease, dystonia, and severe obsessive-compulsive disorder.
应用推荐